Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
about
Optimal usage of the GnRH antagonists: a review of the literatureCabergoline for preventing ovarian hyperstimulation syndromeMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.The Impact of Pituitary Blockage with GnRH Antagonist and Gonadotrophin Stimulation Length on The Outcome of ICSI Cycles in Women Older than 36 YearsMild ovarian stimulation for IVF: 10 years later.A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot studyComparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial.Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran.Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohortDoes the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age?Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.Corifollitropin stimulation in combination with GnRH-antagonists after estradiol valerate pre-treatment. A pilot study on patientfriendly IVF.Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.Observational Study to Assess the Therapeutic Value of Four Ovarian Hyperstimulation Protocols in IVF After Pituitary Suppression with GnRH Antagonists in Normally Responding Women.GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.Should mild stimulation be the order of the day?Optimisation of the follicular phase in IVF/ICSIFertility preservation in girls and young women.The impact of the time interval on in-vitro fertilisation success after failure of the first attempt.Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles.Scheduling GnRH antagonist cycles by a short course of oral estradiol administration during early follicular phase: a comparative study with non-scheduled cycles.The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial.A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase.Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols.Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization-embryo transfer cycle in an unspecifieOvarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.
P2860
Q21245566-BFDC6D30-9DD5-4BF1-87D7-32AE4E31D559Q24203638-A4230E2B-B011-462F-BE0A-2449E409F91DQ30399747-5C8DA10A-AFA1-4071-8DE9-EC8B32E0C294Q33937249-47B6E197-34D9-4FCE-8F98-370EAE7670E3Q34139320-AACFB162-AEBC-4829-A134-36B0810F08CCQ34439774-6174A295-4B2D-4B07-9BC1-897267320474Q34866439-FFED8D55-5616-4A18-BDA7-6CA6508DAA07Q35808082-F9D0AC3F-3003-4F35-B4A1-7406745BDC49Q36074736-82B34BCA-8897-40F4-8853-0573F3323543Q36124732-5C8A8C2D-5B0C-4E21-ABB8-C36FAA6D1FD5Q36295620-0BD387E2-1F52-4195-9A9D-81D2B5A7B1B3Q36335451-BB6B07BF-1BB2-4BAA-889D-B522F07B3FD8Q37326952-E106B5B7-8FE5-44CC-9E95-1522A2C47AAEQ37362092-7BCF156A-5F53-4FEC-9171-3D298F252A7DQ37463040-405EB091-39F1-4530-8CCE-FB09D371F257Q37598922-410CDA9B-B1C7-4CBE-AB10-9A4E9227D435Q37658023-BEB07DAE-62DB-4A52-9D9A-437B252E6B0BQ37709779-83904FE8-EB4E-4448-A036-B8CA01C857F4Q37875896-ED202903-3DC3-4DE1-8321-854403EE929DQ45769769-A50F0E8A-F0F7-45F6-A208-D5FA838203AAQ47135497-49CBA3C1-BF04-4D0A-8A2B-20D5777D42F3Q48578488-23AC37D1-FFBC-4C42-8407-09B9FC0477E3Q48604738-266AC7B8-41BB-4AF5-81ED-D72589CC89B9Q48643865-1E95F383-861F-4A5A-B73F-5A1A8DBA329CQ48653009-DEC86D9B-95C7-4551-A42B-F4030B151E26Q48693072-FF6EF5FF-E135-485E-BA93-8E82AF45F3B5Q49419476-3B2D72DD-38D9-4E34-A5F5-64914F4CAFD9Q55257463-3BB47039-E299-4A45-A4AF-90F4DD6C8EEDQ55279761-32FE3266-EC6F-41ED-84C4-5290353CB84E
P2860
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving the patient's experi ...... GnRH antagonist co-treatment.
@en
Improving the patient's experi ...... GnRH antagonist co-treatment.
@nl
type
label
Improving the patient's experi ...... GnRH antagonist co-treatment.
@en
Improving the patient's experi ...... GnRH antagonist co-treatment.
@nl
prefLabel
Improving the patient's experi ...... GnRH antagonist co-treatment.
@en
Improving the patient's experi ...... GnRH antagonist co-treatment.
@nl
P2093
P2860
P50
P356
P1433
P1476
Improving the patient's experi ...... GnRH antagonist co-treatment.
@en
P2093
Bart C J M Fauser
Candido Tomás
Efstratios Kolibianakis
Georg Griesinger
Juan Garcia-Velasco
Mohamed Aboulghar
P2860
P304
P356
10.1093/HUMREP/DEN468
P407
P577
2009-01-19T00:00:00Z